Company Cash Funds: eXoZymes (EXOZ)

EXOZ (invizyne.com) - company brandmark

eXoZymes Inc (EXOZ) maintains pricing power in niche markets through its biocatalysis patents. The business is sensitive to borrowing costs despite low cyclicality. Currently, the startup is actively forming R&D partnerships. The cash-on-hand metric on the GURU.Markets time chart demonstrates liquidity, where 0.00 indicates the level of this metric.

EXOZ - Invizyne Technologies, Inc. Company Cash Reserve over the range 02/13/2025 - 11/21/2026

Financial and market metric breakdowns for eXoZymes (EXOZ)

- current price and projected stock value:
- company stock exchange capitalization indicators:
Basic company analysis:EXOZ eXoZymes
Product sample of invizyne.com

Developing enzyme systems for biomanufacturing requires significant expenditures on research and technological support. This metric captures the volume of retained earnings, demonstrating the balance between innovation investments and the creation of a financial reserve. It is critical for investors to assess whether excessive cash accumulation limits the growth potential of eXoZymes Inc (EXOZ) capitalization. By analyzing the company's cash dynamics, one can determine the business's level of protection against bankruptcy.

Who eXoZymes Inc competes with

Company Cash Funds Haleon (HLN)|Company Cash Volume Kenvue Inc. (KVUE)|Company Cash Volume VRNA (veronapharma.com)|Company Cash Balance MENS|LGND: Company Cash on Hand|Company Cash Balance AMRX (Amneal Corp)|PRGO (Perrigo Company plc) - Company Cash on Hand|Alvotech - Company Cash Balance|Company Cash on Hand LQDA|Galapagos Genomics (GLPG) - Company Liquid Assets|Company Cash Volume ANIP|Company Cash on Hand Afrezza MNKD|Company Cash Funds Amphastar AMPH|Company Liquid Assets Pacira BioSciences (PCRX)|ARS Corp - Company Cash Volume|TBPH: Company Cash Funds|AQST: Company Cash Volume|SCPH - Company Liquid Assets|TECX (Tectonic) - Company Cash Volume|Company Cash Reserve Tonix Pharmaceuticals Holding Corp. TNXP|Company Cash Funds SXT Pharmaceuticals (SXTC)|Company Cash Volume Eupraxia Pharmaceuticals Inc. (EPRX)|Company Cash Funds BioHarvest Sciences BHST|Company Cash Volume oramed.com ORMP|ENTX - Company Cash Funds|Company Liquid Assets MindWalk Holdings HYFT|ABVC: Company Cash Volume|Company Cash on Hand Cumberland Pharmaceuticals Inc.|Company Cash Funds Quantum BioPharma Limited|FGEN: Company Cash Balance|Company Cash Volume TELO|Rani Therapeutics Holdings, Inc. - Company Cash and Cash Equivalents|Company Cash Funds Synergy CHC Corp. SNYR|Company Cash Balance RLYB|LEXX: Company Cash on Hand|Company Cash Balance PULM (Pulmatrix Corporation)|Pheton Holdings Limited (PTHL) - Company Cash Funds|Company Cash on Hand Aptorum|Company Cash on Hand LYRA|Impact BioMedical Inc - Company Total Cash Volume|Company Cash Volume TNFA|YCBD - Company Cash Reserve|PainReform Ltd. - Company Cash on Hand|CYTO (Auris Medical) - Company Total Cash Volume|LIPO - Company Cash Funds|Company Cash Balance OPTN (OptiNose)|PIRS: Company Cash Volume|Procaps Group S.A. (PROC) - Company Cash Volume|PTPI (Petros Pharma) - Company Cash Volume|QLI: Company Cash Balance|Company Cash Volume SLRN|TFFP (TFF Pharmaceuticals Inc.) - Company Cash Balance